Old Mission Capital’s Celularity CELU Stock Holding History

Old Mission Capital’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,549	Closed	-$34.9K	–	1316
2023 Q2	$34.9K	Buy	+6,549	New	+$42K	﹤0.01%	1185

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Old Mission Capital's CELU Position: Q3 2023 in Review

Old Mission Capital sold out of Celularity (CELU) in Q3 2023, closing a stake of 6,549 shares — an estimated $34.9K sold.

Old Mission Capital first reported a position in CELU in Q2 2023 and held it in 1 quarter. The position peaked at $34.9K in Q2 2023. 45 funds tracked by Wall St. Rank hold CELU as of Q3 2023.

Old Mission Capital reported no remaining Celularity position as of Q3 2023 after selling out during the quarter.
Old Mission Capital sold 6,549 Celularity shares in Q3 2023, an estimated $34.9K.
Old Mission Capital first reported a position in Celularity in Q2 2023 and held it in 1 quarter.
Old Mission Capital's Celularity position peaked at $34.9K in Q2 2023.
45 funds tracked by Wall St. Rank held Celularity as of Q3 2023.

Based on Old Mission Capital's 13F filing for Q3 2023, filed 15 Nov 2023.